Development of Clinical Trials: 'Why It is Necessary and How It can be Achieved?'

Chul Joon Kim

doi:10.5124/jkma.2003.46.12.1064

J Korean Med Assoc > Volume 46(12); 2003 > Article

Kim: Development of Clinical Trials -'Why It is Necessary and How It can be Achieved?'-

Opinion

Journal of the Korean Medical Association

Journal of the Korean Medical Association 2003; 46(12): 1064-1069.

Published online: December 31, 2003

DOI: http://dx.doi.org/10.5124/jkma.2003.46.12.1064

Development of Clinical Trials -'Why It is Necessary and How It can be Achieved?'-

Chul Joon Kim

charles_kim@merck.com

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1. Griffin JP, O'Grady J. The Regulation of Medical Products. BMJ 2003.

2. Spilker B. Guide to Clinical trials 1996;Lippincott-Raven.

3. Fletcher AJ, Edwards LD, Fox AW, Stoner P. Principle and Practice of Pharmaceutical Medicine 2002;Wiley.

5. Woolley K, Woolley M. Clinical Trials in Australia : Findings out the FACTS(First Australian Clinical Trial Survey) 2003;GCPI. 13-16.

6. Baume PE. A Question of Balance : Report on the Future of Drug Evaluation in Australia 1991;Canberra: AGPS.

Development of Clinical Trials -'Why It is Necessary and How It can be Achieved?'-

References

Figure 1

Figure 2

Figure 3